ATAC trial update

Anthony Howell; Gilberto de Castro

doi:10.1016/S0140-6736(05)74801-7

ATAC trial update

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1225; author reply 1225-6
Journal	Lancet (London, England)
Volume	365
Issue number	9466
DOIs	https://doi.org/10.1016/S0140-6736(05)74801-7
Publication status	Published - 7 Apr 2005

Keywords

Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Breast Neoplasms
Chemotherapy, Adjuvant
Female
Humans
Nitriles
Survival Rate
Tamoxifen
Triazoles
Comment
Letter

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(05)74801-7

Cite this

@article{52e5783cdee44d7096f68891150dc72d,

title = "ATAC trial update",

keywords = "Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Breast Neoplasms, Chemotherapy, Adjuvant, Female, Humans, Nitriles, Survival Rate, Tamoxifen, Triazoles, Comment, Letter",

author = "Anthony Howell and {de Castro}, Gilberto",

year = "2005",

month = apr,

day = "7",

doi = "10.1016/S0140-6736(05)74801-7",

language = "English",

volume = "365",

pages = "1225; author reply 1225--6",

journal = "Lancet (London, England)",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "9466",

}

TY - JOUR

T1 - ATAC trial update

AU - Howell, Anthony

AU - de Castro, Gilberto

PY - 2005/4/7

Y1 - 2005/4/7

KW - Antineoplastic Agents, Hormonal

KW - Aromatase Inhibitors

KW - Breast Neoplasms

KW - Chemotherapy, Adjuvant

KW - Female

KW - Humans

KW - Nitriles

KW - Survival Rate

KW - Tamoxifen

KW - Triazoles

KW - Comment

KW - Letter

U2 - 10.1016/S0140-6736(05)74801-7

DO - 10.1016/S0140-6736(05)74801-7

M3 - Article

C2 - 15811448

SN - 0140-6736

VL - 365

SP - 1225; author reply 1225-6

JO - Lancet (London, England)

JF - Lancet (London, England)

IS - 9466

ER -